43 results
8-K
EX-99.2
d9apx t450ux
12 Oct 21
Regulation FD Disclosure
7:25am
8-K
EX-99.1
f0ui us5q6f
23 Apr 21
Protara Therapeutics Provides Regulatory Update for TARA-002 for the Treatment of Lymphatic Malformations
7:01am
8-K
EX-1.1
1pl0e bwgsbqh
23 Sep 20
Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
9:08am
8-K
EX-1.2
jnu4pki ban
23 Sep 20
Protara Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock
9:08am
8-K/A
EX-99.1
zndp7bemdhve xsl7i9
19 Mar 20
Financial Statements and Exhibits
9:31pm
424B3
64y5j801z0wqy
11 Feb 20
Prospectus supplement
4:16pm
8-K
EX-10.4
exdsznuqp5ey g2
10 Jan 20
ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics
5:25pm
424B3
xsef2lzws deg
19 Dec 19
Prospectus supplement
4:24pm